| Product Name |
Atorvastatin EP Impurity H / Atorvastatin Related Compound H (USP)
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Enzyme Inhibitors, Fine Chemicals |
| CAS No |
125995-03-1 |
| Catalog Number |
GS.92.AT0.08 |
| Chemical Name/Synonyms |
Atorvastatin Lactone ; 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide; (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H-pyran-2-one; Atorvastatin-Lactone; 5-(4-Fluorophenyl)-1-{2-[(2R ,4R )-4-hydroxy-6-oxotetrahydro-2H -pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H -pyrrole-3-carboxamide |
| Molecular Weight |
540.62 |
| Molecular Formula |
C33H33FN2O4 |
| Purity |
NLT 95% |
| Appearance |
Off-White to Pale Yellow Solid |
| Solubility |
Methanol, Chloroform |
| Applications |
Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation. |
| Inventory Status |
Ready Stock
Please as a distributor to view package sizes and prices
|
